2. Search Result
Search Result
Results for "

nuak

" in MedChemExpress (MCE) Product Catalog:

30

Inhibitors & Agonists

1

Recombinant Proteins

1

Antibodies

6

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-147141
    HS-276
    2 Publications Verification

    		 IRAK TNF Receptor Casein Kinase Interleukin Related Inflammation/Immunology
    HS-276 is an orally active, potent and highly selective TAK1 inhibitor, with a Ki of 2.5 nM. HS-276 shows significant inhibition of TAK1, CLK2, GCK, ULK2, MAP4K5, IRAK1, NUAK, CSNK1G2, CAMKKβ-1, and MLK1, with IC50 values of 8.25, 29, 33, 63, 125, 264, 270, 810, 1280, and 5585 nM, respectively. HS-276 reduces the expression of TNF, IL-6, and IL-1β. HS-276 can be used for rheumatoid arthritis (RA) research .
    HS-276
  • HY-15802
    WZ4003
    5+ Cited Publications

    		 AMPK Cancer
    WZ4003 is the first potent and highly specific NUAK kinase inhibitor with IC50 of 20 nM/100 nM for NUAK1 (ARK5)/NUAK2, without significant inhibition on other 139 kinases.
    WZ4003
  • HY-100006
    MRT68921
    Maximum Cited Publications
    27 Publications Verification

    		 ULK Reactive Oxygen Species (ROS) Apoptosis GSK-3 Bcl-2 Family Cancer
    MRT68921 is a potent NUAK1/ULK1 dual inhibitor. MRT68921 inhibits ULK1 and ULK2 with IC50 values of 2.9 nM and 1.1 nM, respectively. MRT68921 can block cells autophagy and kill tumor cells by breaking the balance of oxidative stress signals. MRT68921 can inhibit cell proliferation and induce ROS production and apoptosis. MRT68921 can be used for the research of cancer, such as breast cancer .
    MRT68921
  • HY-12334
    HTH-01-015
    1 Publications Verification

    		 AMPK Cancer
    HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 μM).
    HTH-01-015
  • HY-100006A
    MRT68921 dihydrochloride
    Maximum Cited Publications
    27 Publications Verification

    		 ULK Reactive Oxygen Species (ROS) Apoptosis GSK-3 Bcl-2 Family Cancer
    MRT68921 dihydrochloride is a potent NUAK1/ULK1 dual inhibitor. MRT68921 dihydrochloride inhibits ULK1 and ULK2 with IC50 values of 2.9 nM and 1.1 nM, respectively. MRT68921 dihydrochloride can block cells autophagy and kill tumor cells by breaking the balance of oxidative stress signals. MRT68921 dihydrochloride can inhibit cell proliferation and induce ROS production and apoptosis. MRT68921 dihydrochloride can be used for the research of cancer, such as breast cancer .
    MRT68921 dihydrochloride
  • HY-156397
    HTH-02-006

    		AMPK YAP Cancer
    HTH-02-006 is a NUAK2 inhibitor, with an IC50 value of 126 nM. HTH-02-006 inhibits NUAK2-mediated signaling by reducing phosphorylation of its substrate MYPT1 at S445 and downstream MLC. HTH-02-006 shows growth inhibitory efficacy in YAP-high cancer cells (HuCCT-1, SNU475). HTH-02-006 significantly suppresses YAP-induced hepatomegaly (reduced liver/body weight ratio) in TetO-YAP S127A transgenic mice and demonstrates significant anti-tumor efficacy in mice bearing HMVP2 prostate cancer allografts. HTH-02-006 can be used for the study of liver cancer and prostate cancer .
    HTH-02-006
  • HY-162708
    KHKI-01128

    		AMPK Cancer
    KHKI-01128 is a NUAK2 inhibitor, with an IC50 of 0.024 μM. KHKI-01128 exhibits potent anticancer activity against SW480 colorectal cancer cells .
    KHKI-01128
  • HY-162709
    KHKI-01215

    		Apoptosis YAP Cancer
    KHKI-01215 is an inhibitor for NUAK2 with an IC50 of 0.052 μM. KHKI-01215 inhibits the proliferation of cancer cell SW480 with an IC50 of 3.16 μM, induces apoptosis in SW480. KHKI-01215 inhibits the YAP signaling pathway .
    KHKI-01215
  • HY-170360
    UCB9386

    		AMPK JAK Cancer
    UCB9386 is the selective and brain penetrant inhibitor for Nuak1 with a pIC50 of 10.1. UCB9386 inhibits Nuak2 and Kak2 with an inhibition rate of ca. 50% at 10 nM .
    UCB9386
  • HY-RS09645
    Nuak1 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Nuak1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nuak1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nuak1 Mouse Pre-designed siRNA Set A
    Nuak1 Mouse Pre-designed siRNA Set A
  • HY-153058
    LRRK2-IN-8

    		LRRK2 JAK AMPK Neurological Disease Cancer
    LRRK2-IN-8 is a LRRK2 inhibitor. LRRK2-IN-8 inhibits LRRK2 (wt) and LRRK2 (G2019) with IC50s lower than 10 nM, and inhibits TYK2 and NUAK1 with IC50s of 10-100 nM .
    LRRK2-IN-8
  • HY-153103
    LRRK2/NUAK1/TYK2-IN-1

    		LRRK2 JAK AMPK Inflammation/Immunology
    LRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC50 values lower than 10 nM. LRRK2/NUAK1/TYK2-IN-1 can be used for autoimmune disease research .
    LRRK2/NUAK1/TYK2-IN-1
  • HY-100006B
    MRT68921 hydrochloride

    		ULK Reactive Oxygen Species (ROS) Apoptosis GSK-3 Bcl-2 Family Cancer
    MRT68921 hydrochloride is a potent NUAK1/ULK1 dual inhibitor. MRT68921 hydrochloride inhibits ULK1 and ULK2 with IC50 values of 2.9 nM and 1.1 nM, respectively. MRT68921 hydrochloride can block cells autophagy and kill tumor cells by breaking the balance of oxidative stress signals. MRT68921 hydrochloride can inhibit cell proliferation and induce ROS production and apoptosis. MRT68921 hydrochloride can be used for the research of cancer, such as breast cancer .
    MRT68921 hydrochloride
  • HY-178171
    ARUK2010489

    		AMPK CDK Neurological Disease
    ARUK2010489 (Compound 23) is a potent, selective and brain-penetrant NUAK1 inhibitor with a pIC50 of 8.7. ARUK2010489 also inhibits CDK2, CDK4 and CDK6 activity, with inhibitory rate of 7%, 39% and 26% at 1 μM. ARUK2010489 can be used for the research of neurological disease, such as Alzheimer’s disease (AD) .
    ARUK2010489
  • HY-172127
    NUAK1-IN-1

    		AMPK CDK Neurological Disease Cancer
    NUAK1-IN-1 (Compound 9) is a NUAK1 (IC50 of 5.012 nM) and CDK4 inhibitor. NUAK1-IN-1 can be used in cancer, neurodevelopmental disorders and Alzheimer's disease research .
    NUAK1-IN-1
  • HY-172128
    NUAK1-IN-2

    		AMPK CDK Neurological Disease Cancer
    NUAK1-IN-2 (Compound 24) is a NUAK1 (IC50 of 3.162 nM) and CDK2/4/6 inhibitor. NUAK1-IN-2 can be used in cancer, neurodevelopmental disorders and Alzheimer's disease research .
    NUAK1-IN-2
  • HY-E70850
    NuaK1(ARK5) Recombinant Human Active Protein Kinase

    		AMPK Cancer
    NuaK1 (ARK5) is a downstream effector of Akt and is activated in response to cellular hypoxia and nutrient starvation. NuaK1(ARK5) Recombinant Human Active Protein Kinase is a recombinant NuaK1(ARK5) protein that can be used to study NuaK1(ARK5)-related functions .
    NuaK1(ARK5) Recombinant Human Active Protein Kinase
  • HY-E70851
    Nuak2 Recombinant Human Active Protein Kinase

    		AMPK Cancer
    NUAK2 is a member of the SNF1/AMP kinase (AMPK) family (serine/threonine kinases) that is regulated by the putative tumor suppressor LKB1 (20-23) and also by death receptor signaling through NF-κB. Nuak2 Recombinant Human Active Protein Kinase is a recombinant Nuak2 protein that can be used to study Nuak2-related functions .
    Nuak2 Recombinant Human Active Protein Kinase
  • HY-RS09648
    Nuak2 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Nuak2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nuak2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nuak2 Mouse Pre-designed siRNA Set A
    Nuak2 Mouse Pre-designed siRNA Set A
  • HY-RS09644
    NUAK1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    NUAK1 Human Pre-designed siRNA Set A contains three designed siRNAs for NUAK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    NUAK1 Human Pre-designed siRNA Set A
    NUAK1 Human Pre-designed siRNA Set A
  • HY-RS09647
    NUAK2 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    NUAK2 Human Pre-designed siRNA Set A contains three designed siRNAs for NUAK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    NUAK2 Human Pre-designed siRNA Set A
    NUAK2 Human Pre-designed siRNA Set A
  • HY-RS09646
    Nuak1 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Nuak1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nuak1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nuak1 Rat Pre-designed siRNA Set A
    Nuak1 Rat Pre-designed siRNA Set A
  • HY-RS09649
    Nuak2 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Nuak2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nuak2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nuak2 Rat Pre-designed siRNA Set A
    Nuak2 Rat Pre-designed siRNA Set A
  • HY-178168
    ARUK2010694

    		AMPK CDK Neurological Disease
    ARUK2010694 (Compound 20) is a potent and selective NUAK1 inhibitor with a pIC50 of 8.7. ARUK2010694 also inhibits CDK2, CDK4 and CDK6 activity, with inhibitory rate of 13%, 63% and 32% at 1 μM. ARUK2010694 can be used for the research of neurological disease, such as Alzheimer’s disease (AD) .
    ARUK2010694
  • HY-182361
    NUAK1-IN-3

    		AMPK JAK Cadherin Cancer
    NUAK1-IN-3 is a potent and selective NUAK1 inhibitor with an IC50 of 0.49 nM. NUAK1-IN-3 also inhibits NUAK2 and JAK3 with IC50 values of 265 and 225 nM. NUAK1-IN-3 engages Glu139 of NUAK1, forms a salt bridge between its bicyclic ring nitrogen and Asp142, and uses a fluorine atom to enhance hydrophobic binding interactions. NUAK1-IN-3 attenuates MYPT1 phosphorylation, suppresses the NUAK1-MYPT1 signaling axis, and inhibits proliferation, migration, and invasion of triple-negative breast cancer cells. NUAK1-IN-3 reverses TGF-β1-induced epithelial-mesenchymal transition (EMT) marker alterations, downregulates Snail and N-cadherin, and upregulates E-cadherin in tumor tissues. NUAK1-IN-3 suppresses tumor growth in triple-negative breast cancer xenograft models. NUAK1-IN-3 can be used for the research of triple-negative breast cancer .
    NUAK1-IN-3
  • HY-E70802
    Biotin-Nuak2 Recombinant Human Active Protein Kinase

    		AMPK Cancer
    NUAK2 is a member of the SNF1/AMP kinase (AMPK) family (serine/threonine kinases) that is regulated by the putative tumor suppressor LKB1 (20-23) and also by death receptor signaling through NF-κB. Biotin-Nuak2 Recombinant Human Active Protein Kinase is a recombinant Nuak2 protein that can be used to study Nuak2-related functions, and is biotinylated .
    Biotin-Nuak2 Recombinant Human Active Protein Kinase
  • HY-182743
    OICR19451

    		AMPK MARK YAP Cancer
    OICR19451 is an orally active dual NUAK1/NUAK2 and MARK2/MARK3 kinase inhibitor, with IC50 values of 12 nM and 10 nM against NUAK1 and NUAK2, and 101 nM and 124 nM against MARK2 and MARK3, respectively. OICR19451 modulates the Hippo signaling pathway, increases the phosphorylation level of YAP, enhances the cytoplasmic localization of YAP/TAZ, and inhibits the expression of oncogenes. OICR19451 inhibits cancer cell growth, reduces metastasis, promotes tumor capsule formation, and improves mouse survival in an orthotopic breast cancer model. OICR19451 can be used for research related to triple-negative breast cancer .
    OICR19451
  • HY-100006AR
    MRT68921 dihydrochloride (Standard)

    		ULK Reference Standards Reactive Oxygen Species (ROS) Apoptosis GSK-3 Bcl-2 Family Cancer
    MRT68921 (dihydrochloride) (Standard) is the analytical standard of MRT68921 (dihydrochloride) (HY-100006A). This product is intended for research and analytical applications. MRT68921 dihydrochloride is a potent NUAK1/ULK1 dual inhibitor. MRT68921 dihydrochloride inhibits ULK1 and ULK2 with IC50 values of 2.9 nM and 1.1 nM, respectively. MRT68921 dihydrochloride can block cells autophagy and kill tumor cells by breaking the balance of oxidative stress signals. MRT68921 dihydrochloride can inhibit cell proliferation and induce ROS production and apoptosis. MRT68921 dihydrochloride can be used for the research of cancer, such as breast cancer .
    MRT68921 dihydrochloride (Standard)
  • HY-147141A
    HS-276 hydrochloride

    		IRAK TNF Receptor Casein Kinase Interleukin Related Inflammation/Immunology
    HS-276 hydrochloride is an orally active, potent and highly selective TAK1 inhibitor, with a Ki of 2.5 nM. HS-276 hydrochloride shows significant inhibition of TAK1, CLK2, GCK, ULK2, MAP4K5, IRAK1, NUAK, CSNK1G2, CAMKKβ-1, and MLK1, with IC50 values of 8.25, 29, 33, 63, 125, 264, 270, 810, 1280, and 5585 nM, respectively. HS-276 hydrochloride reduces the expression of TNF, IL-6, and IL-1β. HS-276 hydrochloride can be used for rheumatoid arthritis (RA) research .
    HS-276 hydrochloride
  • HY-147141B
    HS-276 formic

    		IRAK TNF Receptor Casein Kinase Interleukin Related Inflammation/Immunology
    HS-276 formic is an orally active, potent and highly selective TAK1 inhibitor, with a Ki of 2.5 nM. HS-276 formic shows significant inhibition of TAK1, CLK2, GCK, ULK2, MAP4K5, IRAK1, NUAK, CSNK1G2, CAMKKβ-1, and MLK1, with IC50 values of 8.25, 29, 33, 63, 125, 264, 270, 810, 1280, and 5585 nM, respectively. HS-276 formic reduces the expression of TNF, IL-6, and IL-1β. HS-276 formic can be used for rheumatoid arthritis (RA) research .
    HS-276 formic

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: